Search Results 691-700 of 14773 for anti-TNF drugs

  1. ... TREATMENT,6554 230000003,HC WOUND VAC TX 1ST ... DRUG,171 260000009,HC IV PUSH EA ADD SEQ NEW ... ANTI-XA,157 301000889,HC RIVAROXABAN ANTI-XA,157 ...

  2. Peginterferon Alfa-2a (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. Rheumatology - Conditions treated - Mayo Clinic

    Mayo Clinic rheumatologists have expertise in the treatment of inflammatory diseases of blood vessels (vasculitis) and systemic autoimmune connective tissue ...

  4. Antimyasthenic (Oral Route, Parenteral Route) Proper Use - Mayo Clinic

    Dosing. The dose medicines in this class will be different for different patients. Follow your doctor's orders or the directions on the label. The following ...

  5. Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... In this study, we assessed therapy with anti-TNF agents in patients with TA ...

  6. CAR-T Cell Therapy Program - Overview - Mayo Clinic

    Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...

  7. Mogamulizumab-Kpkc (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Poteligeo. Descriptions. Mogamulizumab-kpkc injection is ...

  8. Mayo Clinic Minute: What is CAR-T cell therapy?

    CAR-T cell therapy is a personalized treatment giving hope to patients diagnosed with various lymphomas. Learn more from Mayo Clinic.

  9. Radiopharmaceutical (Oral Route) Description and Brand Names - Mayo Clinic

    Radiopharmaceuticals are agents used to diagnose certain medical problems or treat certain diseases. They may be given to the patient in several different ways.

  10. Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL - Mayo Clinic

    Being treated with anti-TNF therapies or has been treated with an anti-TNF therapy within 5 half-lives of randomization. Participating Mayo Clinic locations.